Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

The American Journal of Clinical Nutrition, 2026
Height variation independent of known genetic variants and health in later life: a cohort study

Zhang Y., Li Y., Xue X. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPathophysiologyPlasma

JACC: Basic to Translational Science, 2026
Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease

Tan E., Sim M., Choi H. et al.

Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma

Metabolism, 2026
Pathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes

Deng K., Hameete A., Schrauwen P. et al.

Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma

Clinical Gastroenterology and Hepatology, 2026
Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank

Kim H., Rezaee-Zavareh M., Wang Y. et al.

Olink Explore 3072/384HepatologyNutritional SciencePathophysiologyPlasma

npj Science of Food, 2026
BHOD: a bone health optimized dietary pattern designed for osteoporosis prevention

Zheng Y., Li Y., Gao Y. et al.

Olink Explore 3072/384Nutritional ScienceOrthopedicsPathophysiologyPlasma

BMC Neurology, 2026
A preliminary analysis of the inflammatory protein landscape in the CSF of mid- to late-stage Parkinson’s disease: associations with motor severity and subtypes

Guo Y., Liu W., Bu W. et al.

Olink Target 96NeurologyPatient StratificationCSF

Comprehensive Physiology, 2026
Insight Into the Biological Link Between Novel Adiposity Indices and Incident Heart Failure

Yang Y., Li J., Xiao X. et al.

Olink Explore 3072/384Metabolic DiseasesCVDPathophysiologyPlasma

Frontiers in Medicine, 2026
Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics

Zhu L., Chen W., Shen N. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyTissue Lysate

Journal of Advanced Research, 2026
Integrating clinical, proteomics, and polygenic scores to improve cardiovascular risk prediction: a prospective cohort study

Ding Y., Hong G., Wang Z. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Gut Microbes, 2026
Multi-omics analysis of saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression

Vaaben T., Lützhøft D., Hedin K. et al.

Olink Target 48 MouseOncologyNutritional SciencePathophysiologyMouse Plasma

Frontiers in Immunology, 2026
TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis

Evangelista J., Nisperuza Vidal A., Xu D. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyMouse Tissue Lysate

Aging Cell, 2026
Bidirectional Relationship and Shared Mechanisms Between Sarcopenia and Osteoporosis: An Observational Study Integrating Genomic, Proteomic, and Metabolomic Data

Xu S., Wen S., Zong X. et al.

Olink Explore 3072/384AgingOrthopedicsPathophysiologyPlasma

The Journal of Nutrition, 2026
Oat-Rich Low-Gluten Diet Modulates Plasma Short-Chain Fatty Acids without Significant Changes in Fecal Microbiome or Inflammatory Markers—A Randomized Clinical Trial in People with Cardiometabolic Risk

Mannila E., Gómez-Gallego C., Muluh G. et al.

Olink Target 48Nutritional SciencePathophysiologyPlasma

Journal of Clinical Investigation, 2026
Rheumatoid factor production is genetically and molecularly distinct from rheumatoid arthritis

Hocaoglu M., Sawalha A.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Inflammation Research, 2026
Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury

Van Nynatten L., Tweddell D., Daley M. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

International Journal of Molecular Sciences, 2026
APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis

Dźwigała M., Sys D., Życka-Krzesińska J. et al.

RevealImmunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationSerum

Journal of Inflammation Research, 2026
Paired Tear Fluid – Plasma Inflammatory Profiling Identifies Compartment-Specific Biomarkers for Diabetic Retinopathy and Diabetic Macular Edema

Yu T., Li S., Cheng F. et al.

Olink Target 96Metabolic DiseasesOphthalmologyPatient StratificationPlasmaTear Fluid

Psychotherapy and Psychosomatics, 2026
Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways

Wei W., Cheng B., He D. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Journal of Cardiovascular Translational Research, 2026
The Immediate Impact of Infarct Size on the Systemic Inflammatory Response: IL-6 as Central Mediator Identified through Biomarker and Proteomic Profiling

Los J., Mensink F., Bulut ?. et al.

Olink Target 96CVDPatient StratificationPlasma

Scientific Reports, 2026
Plasma COL3A1 propeptide as a promising prognostic marker in oral squamous cell carcinoma

Magan M., Gu X., Sgaramella N. et al.

Olink Explore 3072/384OncologyPatient StratificationPlasma

4520 publications